Products shown are selected for relevance to Product Reviews
If cleared, CagriSema would become the first injectable to combine a GLP-1 receptor agonist with an amylin analogue, a genuine mechanistic milestone regardless of the comparison with tirzepatide
Delivery methods vary by peptide and include subcutaneous injections, oral capsules, and targeted joint injections
The pull: why people still try it The marketing hits three buttons fast
However, without appropriate nutritional guidance and support from healthcare professionals, there is a real risk that reduced food intake could compromise dietary quality, meaning people may not get enough protein, fibre, vitamins, and minerals essential for maintaining overall health. Access to Treatment and Gaps in Care Guidance from the National Institute for Health and Care Excellence (NICE) recommends semaglutide as a weight management option for people who meet specific criteria, including a body mass index (BMI) of at least 35.0 kg/m2 and comorbidity (that is, they also have other conditions such as type 2 diabetes, cardiovascular disease, etc)
The weight loss management program cannot solely rely on semaglutide to suppress appetite
